Cited by 773PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and CancerAdvanced Breast Cancer Therapies

The DOI matches its Crossref record; 129 of the 131 references it cites were found in a registry or an index.

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway

Polivka, Jiri, Janku, Filip·2014·Pharmacology & Therapeutics

DOI 10.1016/j.pharmthera.2013.12.004

Open this paper in CoChat — free account

Abstract

Aberrations in various cellular signaling pathways are instrumental in regulating cellular metabolism, tumor development, growth, proliferation, metastasis and cytoskeletal reorganization. The fundamental cellular signaling cascade involved in these processes, the phosphatidylinositol 3-kinase/protein kinase-B/mammalian target of rapamycin (PI3K/AKT/mTOR), closely related to the mitogen-activated protein kinase (MAPK) pathway, is a crucial and intensively explored intracellular signaling pathway in tumorigenesis. Various activating mutations in oncogenes together with the inactivation of tumor suppressor genes are found in diverse malignancies across almost all members of the pathway. Substantial progress in uncovering PI3K/AKT/mTOR alterations and their roles in tumorigenesis has enabled the development of novel targeted molecules with potential for developing efficacious anticancer treatment. Two approved anticancer drugs, everolimus and temsirolimus, exemplify targeted inhibition of PI3K/AKT/mTOR in the clinic and many others are in preclinical development as well as being tested in early clinical trials for many different types of cancer. This review focuses on targeted PI3K/AKT/mTOR signaling from the perspective of novel molecular targets for cancer therapy found in key pathway members and their corresponding experimental therapeutic agents. Various aberrant prognostic and predictive biomarkers are also discussed and examples are given. Novel approaches to PI3K/AKT/mTOR pathway inhibition together with a better understanding of prognostic and predictive markers have the potential to significantly improve the future care of cancer patients in the current era of personalized cancer medicine.

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2013.12.004

Cites

129 of 129 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Hudes, G. R., Carducci, M. A., Tomczak, P., Dutcher, J. P., Figlin, R. A., Kapoor, A., Starosławska, E., Sosman, J. A., McDermott, D. F., Bodrogi, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066838 · Cited by 3,645
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
Motzer, R. J., Escudier, B., Oudard, S., Hutson, T. E., Porta, C., Bracarda, S., Grünwald, V., Thompson, J. A., Figlin, R. A., Hollaender, N., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61039-9 · Cited by 3,019
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
Yao, J. C., Shah, M. H., Ito, T., Lombard‐Bohas, C., Wolin, E. M., Cutsem, E. V., Hobday, T. J., Okusaka, T., Capdevila, J., de Vries, E. G. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009290 · Cited by 2,879

Show all 131 references

Research works printed but not linked: 1

Janku, 2011, Loss of PTEN expression in patients treated with PI3K/AKT/mTOR signaling pathway inhibitors, Cancer Res, 71

Sorted by citations

Items 301–400 of 773

A microRNA signature for the differential diagnosis of salivary gland tumors
Denaro, M., Navari, E., Ugolini, C., Seccia, V., Donati, V. L., Casani, A. P., & Basolo, F. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210968 · Cited by 25
GDNF family receptor alpha 2 promotes neuroblastoma cell proliferation by interacting with PTEN
Li, Z., Xie, J., Fei, Y., Gao, P., Xie, Q., Gao, W., & Xu, Z. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.12.169 · Cited by 25
Insulin promotes invasion and migration of KRASG12D mutant HPNE cells by upregulating MMP‐2 gelatinolytic activity via ERK‐ and PI3K‐dependent signalling
Wang, G., Yin, L., Peng, Y., Gao, Y., Gao, H., Zhang, J., Lv, N., Miao, Y., & Lu, Z. (2019) · Cell Proliferation · doi:10.1111/cpr.12575 · Cited by 27
Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo
Lu, Z.-N., Shi, Z., Dang, Y.-F., Cheng, Y., Guan, Y., Hao, Z.-J., Tian, B., He, H., & Guo, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109478 · Cited by 27
Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer
Chaube, U., Rawal, R., Jha, A., Variya, B. C., & Bhatt, H. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104501 · Cited by 26
Adaptive responses to mTOR gene targeting in hematopoietic stem cells reveal a proliferative mechanism evasive to mTOR inhibition
Fan, C., Zhao, C., Zhang, F., Kesarwani, M., Tu, Z., Cai, X., Davis, A. K., Xu, L., Hochstetler, C. L., Chen, X., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020102118 · Cited by 27
Effect of Oversulfation on the Composition, Structure, and In Vitro Anti-Lung Cancer Activity of Fucoidans Extracted from Sargassum aquifolium
Hsiao, H., Wu, T.-C., Tsai, Y., Kuo, C., Huang, R.-H., Hong, Y., & Huang, C.-Y. (2021) · Marine Drugs · doi:10.3390/md19040215 · Cited by 26
Sphingosine 1-phosphate receptor 2 promotes the onset and progression of non-alcoholic fatty liver disease-related hepatocellular carcinoma through the PI3K/AKT/mTOR pathway
Wang, G., Zhang, X., Zhou, Z., Song, C., Jin, W., Zhang, H., Wu, W., Yi, Y., Cui, H., Zhang, P., et al. (2023) · Discover Oncology · doi:10.1007/s12672-023-00611-8 · Cited by 27
Circular RNAs as the pivotal regulators of epithelial-mesenchymal transition in gastrointestinal tumor cells
Mahmoudian, R. A., Akhlaghipour, I., Lotfi, M., Shahidsales, S., & Moghbeli, M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154472 · Cited by 27
Methylglyoxal displays colorectal cancer-promoting properties in the murine models of azoxymethane and CT26 isografts
Lin, J., Wu, C., & Yen, G. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.020 · Cited by 26
IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiforme
Polívka, J., Pešta, M., Pitule, P., Hes, O., Holubec, L., Polívka, J., Kubíková, T., & Tonar, Z. (2018) · Oncotarget · doi:10.18632/oncotarget.24536 · Cited by 28
NLGN3 promotes neuroblastoma cell proliferation and growth through activating PI3K/AKT pathway
Li, Z., Gao, W., Fei, Y., Gao, P., Xie, Q., Xie, J., & Xu, Z. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172423 · Cited by 26
PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells
Qi, L., Toyoda, H., Xu, D., Zhou, Y., Sakurai, N., Amano, K., Kihira, K., Hori, H., Azuma, E., & Komada, Y. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0239-4 · Cited by 29
Exploring the tumor-suppressive role of miRNA-200c in head and neck squamous cell carcinoma: Potential and mechanisms of exosome-mediated delivery for therapeutic applications
Kishta, M. S., Khamis, A., Am, H., Elshaar, A. H., & Gül, D. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102216 · Cited by 25
Repositioning gemigliptin for the alleviation of thioacetamide-induced liver fibrosis in rats: Targeting TLR4/MAPK, SIRT1/AMPK/Nrf2, PI3K/AKT/mTOR axis and apoptosis
Almalki, R. S., Gazzaz, M., Miski, S. F., Fayed, H. M., Mohamed, B. M. S. A., Hessin, A. F., Afifi, S. M., Esatbeyoglu, T., Korany, R. M. S., & Elbaset, M. A. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107192 · Cited by 25
Heterophyllin B inhibits the adhesion and invasion of ECA-109 human esophageal carcinoma cells by targeting PI3K/AKT/β-catenin signaling
Tantai, J., Zhang, Y., & Zhao, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4659 · Cited by 25
Zingerone Nanotetramer Strengthened the Polypharmacological Efficacy of Zingerone on Human Hepatoma Cell Lines
Kung, M., Lin, P., Huang, S., Tai, M., Hsieh, S., Wu, C., Yeh, B., Wu, W., & Hsieh, S. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b14559 · Cited by 25
Gambogic acid affects ESCC progression through regulation of PI3K/AKT/mTOR signal pathway
Yu, J., Wang, W., Yao, W., Zhao, Y., Gao, P., Liu, M., Wang, H., Chen, S., Wang, D., Wang, W., et al. (2020) · Journal of Cancer · doi:10.7150/jca.41115 · Cited by 25
Effective suppression of triple negative breast cancer by paclitaxel nanoparticles conjugated with transmembrane TNF-α monoclonal antibody
Liu, J., Wang, P., Huang, B., Cheng, Q., Duan, Y., Chen, L., Ma, T., Zhu, C., Li, D., Fan, W., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121969 · Cited by 25
Arctigenin Triggers Apoptosis and Autophagy via PI3K/Akt/mTOR Inhibition in PC-3M Cells
Sun, B.-L., Cai, E., Zhao, Y. H., Wang, Y., Yang, L., & Wang, J. (2021) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c21-00021 · Cited by 25
Recent insights into autophagy and metals/nanoparticles exposure
Li, Q., Feng, Y., Wang, R., Liu, R., Ba, Y., & Huang, H. (2023) · Toxicological Research · doi:10.1007/s43188-023-00184-2 · Cited by 25
Canonical and new generation anticancer drugs also target energy metabolism
Rodríguez‐Enríquez, S., Gallardo‐Pérez, J. C., Hernández‐Reséndiz, I., Marín‐Hernández, Á., Pacheco-Velázquez, S. C., López‐Ramírez, S. Y., Rumjanek, F. D., & Moreno‐Sánchez, R. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1246-2 · Cited by 24
Could CTSK and COL4A2 be specific biomarkers of poor prognosis for patients with gastric cancer in Asia?—a microarray analysis based on regional population
Feng, Z., Qiao, R., Ren, Z., Hou, X., Feng, J., He, X., & Chen, D. (2020) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2020.03.01 · Cited by 23
Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy
Song, Y., Liao, M., Zhao, X. H., Han, H., Dong, X., Wang, X., Du, M., & Yan, H. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.12.26 · Cited by 24
Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1)viasiRNA-induced cell death in glioblastoma
Serban, F., Daianu, O., Tătăranu, L. G., Artene, Ş.-A., Emami, G., Georgescu, A. M., Alexandru, O., Purcaru, Ş. O., Tache, D. E., Dănciulescu, M. M., et al. (2016) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2016.1209217 · Cited by 24
Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells
Shaik, A. B., Rao, G. K., Kumar, G. B., Patel, N., Reddy, V. S., Khan, I., Routhu, S. R., Kumar, C. G., Veena, I., Shekar, K. C., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.056 · Cited by 24
MYC modulators in cancer: a patent review
Wang, X., Su, X., Cheng, S.-Q., Zhi-yin, S., Huang, Z., & Ou, T. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1612878 · Cited by 25
Knockdown of TRPM7 prevents tumor growth, migration, and invasion through the Src, Akt, and JNK pathway in bladder cancer
Lee, E. H., Chun, S. Y., Kim, B., Yoon, B. H., Lee, J. N., Kim, B. S., Yoo, E. S., Lee, S., Song, P. H., Kwon, T. G., et al. (2020) · BMC Urology · doi:10.1186/s12894-020-00714-2 · Cited by 24
Brassinin enhances the anticancer actions of paclitaxel by targeting multiple signaling pathways in colorectal cancer cells
Yang, M. H., Baek, S. H., Ha, I. J., Um, J., & Ahn, K. S. (2021) · Phytotherapy Research · doi:10.1002/ptr.7095 · Cited by 24
Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population
Zhang, Z., Chen, Q., Zhang, J., Wang, Y., Hu, X., Yin, S., He, M., Guan, S., Qin, W., Xiao, Q., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17250-z · Cited by 24
MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
Zhang, Z., Zhu, J., Huang, Y., Li, W., & Cheng, H. (2018) · Diagnostic Pathology · doi:10.1186/s13000-018-0763-3 · Cited by 23
Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma
Zhang, J., Liu, S., Zhang, D., Ma, Z., & Sun, L. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28644 · Cited by 23
Functional role of SGK3 in PI3K/Pten driven liver tumor development
Cao, H., Xu, Z., Wang, J., Cigliano, A., Pilo, M. G., Ribback, S., Zhang, S., Qiao, Y., Che, L., Pascale, R. M., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5551-2 · Cited by 23
Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1
Zhang, C., Zou, Y., & Dai, D. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109417 · Cited by 23
Curcumin Inhibits HGF-Induced EMT by Regulating c-MET-Dependent PI3K/Akt/mTOR Signaling Pathways in Meningioma
Chen, X., Tian, F., Lun, P., & Feng, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5574555 · Cited by 23
Stingless Bee Propolis: New Insights for Anticancer Drugs
Campos, J. F., dos Santos, H. F., Bonamigo, T., Domingues, N. L. C., Souza, K. D. P., & dos Santos, E. L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/2169017 · Cited by 26
Novel Effects of Statins on Cancer via Autophagy
Mengual, D., Medrano, L. E., Villamizar-Villamizar, W., Osorio-Llanes, E., Mendoza‐Torres, E., & Bolívar, S. (2022) · Pharmaceuticals · doi:10.3390/ph15060648 · Cited by 26
Brevilin A Isolated from Centipeda minima Induces Apoptosis in Human Gastric Cancer Cells via an Extrinsic Apoptotic Signaling Pathway
Lee, D., Kwak, H. J., Kim, B. H., Kim, D., Kim, H. Y., Kim, S. H., & Kang, K. S. (2022) · Plants · doi:10.3390/plants11131658 · Cited by 23
Tetrahydroquinoline: An Efficient Scaffold As mTOR Inhibitor for the Treatment of Lung Cancer
Chaube, U., Dey, R., Shaw, S. K., Patel, B., & Bhatt, H. (2022) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0204 · Cited by 23
Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma
Pang, Y., Wang, Y., Zhou, X., Ni, Z., Chen, W., Liu, Y., & Du, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021464 · Cited by 22
Metabolic codependencies in the tumor microenvironment and gastric cancer: Difficulties and opportunities
Zhao, X., Li, K., Chen, M., & Liu, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114601 · Cited by 23
PI3K/AKT/mTOR pathway-derived risk score exhibits correlation with immune infiltration in uveal melanoma patients
Geng, Y., Geng, Y., Liu, X., Chai, Q., Li, X., Ren, T., & Shang, Q. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1167930 · Cited by 23
Efficacy of Rotundic Acid and Its Derivatives as Promising Natural Anticancer Triterpenoids: A Literature‐Based Study
Bhuia, M. S., Chowdhury, R., Sonia, F. A., Biswas, S., Ferdous, J., El‐Nashar, H. A. S., El‐Shazly, M., & Islam, M. T. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202301492 · Cited by 23
Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes
Teng, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i1.300 · Cited by 26
Autophagy protects against oxidized low density lipoprotein-mediated inflammation associated with preeclampsia
Zhang, Y., Hu, X., Gao, G., Wang, Y., Chen, P., & Ye, Y. (2016) · Placenta · doi:10.1016/j.placenta.2016.09.015 · Cited by 23
(−)-Guaiol regulates autophagic cell death depending on mTOR signaling in NSCLC
Yang, X., Zhu, J., Wu, J., Huang, N. J., Cui, Z., Luo, Y., Sun, F., Pan, Q., Li, Y., & Yang, Q. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1451277 · Cited by 23
HOXA6 inhibits cell proliferation and induces apoptosis by suppressing the PI3K/Akt signaling pathway in clear cell renal cell carcinoma
Wu, F.-X., Wu, S.-S., Tong, H., He, W.-Y., & Gou, X. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4789 · Cited by 21
Human BCR/ABL1 induces chronic myeloid leukemia-like disease in zebrafish
Xu, M., Yin, Y., Ye, Z., Xu, S., Liu, W., Xu, J., Zhang, Y., Liu, Q., Huang, Z., & Zhang, W. (2019) · Haematologica · doi:10.3324/haematol.2019.215939 · Cited by 23
Tangeretin Inhibition of High-Glucose-Induced IL-1β, IL-6, TGF-β1, and VEGF Expression in Human RPE Cells
Dong, Q., & Jiang, Y. (2020) · Journal of Diabetes Research · doi:10.1155/2020/9490642 · Cited by 23
Discovery of a novel tricyclic 4H-thiazolo[5′,4′:4,5]pyrano[2,3-c]pyridine-2-amino scaffold and its application in a PI3Kα inhibitor with high PI3K isoform selectivity and potent cellular activity
Gerspacher, M., Fairhurst, R. A., Mah, R., Roehn-Carnemolla, E., Furet, P., Fritsch, C. M., & Guthy, D. A. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.077 · Cited by 22
Differential roles for Akt and mTORC1 in the hypertrophy of Pten mutant neurons, a cellular model of brain overgrowth disorders
Nikolaeva, I., Kazdoba, T. M., Crowell, B., & D’Arcangelo, G. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.04.026 · Cited by 22
NOD1 deficiency impairs CD44a/Lck as well as PI3K/Akt pathway
Hu, Y., Wu, X. M., Ren, S. S., Cao, L., Nie, P., & Chang, M. X. (2017) · Scientific Reports · doi:10.1038/s41598-017-03258-y · Cited by 22
Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells
Burmi, R. S., Maginn, E. N., Gabra, H., Stronach, E. A., & Wasan, H. S. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1504718 · Cited by 22
PDB-1 from Potentilla discolor Bunge induces apoptosis and autophagy by downregulating the PI3K/Akt/mTOR signaling pathway in A549 cells
Zhang, R., Meng, N.-N., Liu, C., Li, K.-L., Wang, M.-X., Lv, Z.-B., Chen, S.-Y., Guo, X., Wang, X.-K., Wang, Q., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110378 · Cited by 22
Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions
Qian, D. C., Byun, J., Han, Y., Greene, C. S., Field, J. K., Hung, R. J., Brhane, Y., McLaughlin, J. R., Fehringer, G., Landi, M. T., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv440 · Cited by 22
Alisol B 23‑acetate inhibits the viability and induces apoptosis of non‑small cell lung cancer cells via PI3K/AKT/mTOR signal pathway
Yang, L., Xia, X., Meng, L., Wang, Y., & Li, Y. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10355 · Cited by 21
Amauroderma rugosum Protects PC12 Cells against 6‐OHDA‐Induced Neurotoxicity through Antioxidant and Antiapoptotic Effects
Li, J., Li, R., Wu, X., Hoo, R. L. C., Lee, S. M., Cheung, T. M., Ho, B. S.-Y., & Leung, G. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6683270 · Cited by 21
Emerging RAS-directed therapies for cancer
Conroy, M. R., Cowzer, D., Kölch, W., & Duffy, A. G. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2021.07 · Cited by 23
Mapping of mTOR drug targets: Featured platforms for anti-cancer drug discovery
Shams, R. S., Ito, Y., & Miyatake, H. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108012 · Cited by 22
Investigations of primary blast-induced traumatic brain injury
Sawyer, T. W., Josey, T., Wang, Y., Villanueva, M., Ritzel, D. V., Nelson, P., & Lee, J. J. (2017) · Shock Waves · doi:10.1007/s00193-017-0756-2 · Cited by 21
ALPK1 Expression Is Associated with Lymph Node Metastasis and Tumor Growth in Oral Squamous Cell Carcinoma Patients
Chen, P., Hua, C., Hsu, H., Kuo, T., Chung, C., Lee, C., Tsai, M., Yeh, K., & Ko, Y. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.09.003 · Cited by 21
STK33 Promotes the Growth and Progression of Human Pancreatic Neuroendocrine Tumour via Activation of the PI3K/AKT/mTOR Pathway
Zhou, B., Xiang, J., Zhan, C., Liu, J., & Yan, S. (2019) · Neuroendocrinology · doi:10.1159/000501829 · Cited by 21
Synergistic Carcinogenesis of HPV18 and MNNG in Het-1A Cells through p62-KEAP1-NRF2 and PI3K/AKT/mTOR Pathway
Zhang, Y., Ma, Y., Zhao, C., Zhang, H., Pu, Y., & Yin, L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6352876 · Cited by 54
Metformin inhibits epithelial‑mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF‑1α/PKM2/STAT3 pathway
Yin, W., Liu, Y., Liu, X., Ma, X., Sun, B., & Yu, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.12292 · Cited by 21
Identification and optimisation of a 4′,5-bisthiazole series of selective phosphatidylinositol-3 kinase alpha inhibitors
Fairhurst, R. A., Imbach, P. A., Gerspacher, M., Caravatti, G., Furet, P., Zoller, T., Fritsch, C. M., Haasen, D., Trappe, J., Guthy, D. A., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.078 · Cited by 21
Erratum to: PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells
Qi, L., Toyoda, H., Xu, D., Zhou, Y., Sakurai, N., Amano, K., Kihira, K., Hori, H., Azuma, E., & Komada, Y. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0261-6 · Cited by 20
Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors
Joaquim Bellmunt, B., Werner, L. L., Leow, J. J. J., Mullane, S. A., Fay, A. P., Riester, M., Hummelen, P. V., Taplin, M., Choueiri, T. K., Allen, E. M. V., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124711 · Cited by 20
RNA-Seq approach to investigate the effects of melatonin on bone marrow-derived dendritic cells from dextran sodium sulfate-induced colitis mice
Feng, S., Xu, Z., Zhang, Z., Mo, Y., Deng, Y., Li, L., Fei, S., Wu, J., Wang, K., Zhang, Q., et al. (2022) · Toxicology · doi:10.1016/j.tox.2022.153354 · Cited by 21
Akt enhances nerve growth factor-induced axon growth via activating the Nrf2/ARE pathway
XIA, B., LIU, H., Xie, J., Wu, R. J., & Li, Y. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2329 · Cited by 20
On the pathogenesis of mTOR inhibitor‐associated stomatitis ( mIAS )—studies using an organotypic model of the oral mucosa
Sonis, S. T., Andreotta, P., & Lyng, G. (2016) · Oral Diseases · doi:10.1111/odi.12616 · Cited by 20
Asparaginyl endopeptidase enhances pancreatic ductal adenocarcinoma cell invasion in an exosome-dependent manner and correlates with poor prognosis
Yan, Q., Yuan, W., Sun, X. D., Zhang, M.-J., Cen, F., Zhou, S.-Y., Wu, W., Xu, Y., Tong, L.-H., & Ma, Z. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4318 · Cited by 20
Mechanism of bioactive polysaccharide from Lachnum sp. acts synergistically with 5‐fluorouracil against human hepatocellular carcinoma
Zong, S., Li, J., Yang, L., Huang, Q., Hou, G., Ye, Z., & Ye, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28202 · Cited by 20
Identification of miRNA signature associated with BMP2 and chemosensitivity of TMZ in glioblastoma stem-like cells
Guo, X., Luo, Z., Xia, T., Wu, L., Shi, Y., & Li, Y. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.09.002 · Cited by 20
Potential mechanism of traditional Chinese medicine intervention in gastric cancer: targeted regulation of autophagy
Sun, S., Yu, W., Zhang, G., Li, X., Song, L., Lv, Y., & Chen, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1548672 · Cited by 21
Identification of LIFR, PIK3R1, and MMP12 as Novel Prognostic Signatures in Gallbladder Cancer Using Network-Based Module Analysis
Zhao, X., Xu, M., Cai, Z., Yuan, W., Cui, W., & Li, M. D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00325 · Cited by 19
DLX6 promotes cell proliferation and survival in oral squamous cell carcinoma
Liang, J., Liu, J., Deng, Z., Liu, Z., & Liang, L. (2020) · Oral Diseases · doi:10.1111/odi.13728 · Cited by 19
MiR-509-3p Induces Apoptosis and Affects the Chemosensitivity of Cervical Cancer Cells by Targeting the RAC1/PAK1/LIMK1/Cofilin Pathway
Xu, J., Ma, X., Yang, H., Zhang, J., Cai, G., & Yao, N. (2021) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c20-00600 · Cited by 19
Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma
Chen, M., Jiang, Y., Cai, X.-H., Lu, X., & Chao, H. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107829 · Cited by 19
Copper deprivation enhances the chemosensitivity of pancreatic cancer to rapamycin by mTORC1/2 inhibition
Geng, R., Ke, N., Wang, Z., Mou, Y., Xiang, B., Zhang, Z., Ji, X., Zou, J., Wang, D., Yin, Z., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110546 · Cited by 20
Upregulation of RICTOR gene transcription by the proinflammatory cytokines through NF-κB pathway contributes to the metastasis of renal cell carcinoma
Sun, B., Chen, L., Fu, H., Guo, L., Guo, H. B., & Zhang, N. (2015) · Tumor Biology · doi:10.1007/s13277-015-4296-z · Cited by 19
Germline PTPN11 and somatic PIK3CA variant in a boy with megalencephaly-capillary malformation syndrome (MCAP) - pure coincidence?
Döcker, D., Schubach, M., Menzel, M., Spaich, C., Gabriel, H., Zenker, M., Bartholdi, D., & Biskup, S. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.118 · Cited by 19
Daunting but Worthy Goal
Dantal, J., & Campone, M. (2016) · Transplantation · doi:10.1097/tp.0000000000001428 · Cited by 20
Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma
Gong, W., Xiao, Y., Wei, Z., Yao Zong, Y. U. A. N., Qiu, M., Sun, C., Zeng, X. Y., Liang, X., Feng, M., & Chen, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.13798 · Cited by 19
Genistein Protects Genioglossus Myoblast Against Hypoxia-induced Injury through PI3K-Akt and ERK MAPK Pathways
Ding, W., Chen, X., Li, W. J., Fu, Z. F., & Shi, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03484-4 · Cited by 19
Euptox A Induces G1 Arrest and Autophagy via p38 MAPK- and PI3K/Akt/mTOR-Mediated Pathways in Mouse Splenocytes
Mo, Q., Hu, L., Weng, J., Zhang, Y., Zhou, Y., Xu, R., Zuo, Z., Deng, J., Ren, Z., Zhong, Z., et al. (2017) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155417722118 · Cited by 19
The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair
Xu, L., Sun, Z., Wei, X., Tan, H., Kong, P., Li, Z., Yang, Q., Dai, E., & Li, J. (2020) · Journal of bone oncology · doi:10.1016/j.jbo.2020.100290 · Cited by 19
Mere15, a novel polypeptide from Meretrix meretrix, inhibits proliferation and metastasis of human non-small cell lung cancer cells through regulating the PI3K/Akt/mTOR signaling pathway
Biantiao, X., Guo, M., Ma, L., Farooqı, A. A., Wang, L., Qiao, G., Liu, M., Zuo, L., Ye, H., Lin, X., et al. (2021) · Neoplasma · doi:10.4149/neo_2021_210509n628 · Cited by 19
The synergistic antitumor effect of IL-6 neutralization with NVP-BEZ235 in hepatocellular carcinoma
Wang, Y., Miao, X., Jiang, Y., Wu, Z., Zhu, X., Liu, H., Wu, X., Cai, J., Ding, X., & Gong, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04583-5 · Cited by 21
Expression and transcriptional profiling of the LKB1 tumor suppressor in cervical cancer cells
Zhang, X., Chen, H., Wang, X., Zhao, W., & Chen, J. J. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.04.050 · Cited by 19
Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin
Dickinson, S. E., Janda, J., Criswell, J., Blohm-Mangone, K. A., Olson, E. R., Liu, Z., Barber, C., Petricoin, E. F., Calvert, V. S., Einspahr, J. G., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0419 · Cited by 19
Alisol A 24-Acetate and Alisol B 23-Acetate Induced Autophagy Mediates Apoptosis and Nephrotoxicity in Human Renal Proximal Tubular Cells
Wang, C., Feng, L., Ma, L., Chen, H., Tan, X., Hou, X., Song, J., Cui, L., Liu, D., Chen, J., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00172 · Cited by 19
Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E
Li, G., Chong, T., Xiang, X., Yang, J., & Li, H. (2017) · Oncology Reports · doi:10.3892/or.2017.5901 · Cited by 19
β1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway
Tian, T., Li, C., Fu, X., Wang, S.-H., Lü, J., Guo, H., Yao, Y., Nan, K., & Yang, Y. (2018) · Journal of International Medical Research · doi:10.1177/0300060517740807 · Cited by 20
Apiosporamide, A 4-hydroxy-2-pyridone Alkaloid, Induces Apoptosis Via PI3K/Akt Signaling Pathway In Osteosarcoma Cells
Zhang, Y., Zhang, Q., Bao, J., Huang, J., & Zhang, H. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s218692 · Cited by 19
Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs
Al‐Ameer, H. J., Zihlif, M., Maslat, A. O., Al‐Awaida, W., Ayyash, A. M., Imraish, A., Qinna, N. A., Al-Omari, T., Al‐Qaisi, T. S., Al-Zyoud, W. A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-97192-z · Cited by 18
Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway
Teng, Y.-J., Deng, Z., Ouyang, Z.-G., Zhou, Q., Mei, S., Fan, X., Wu, Y., Long, H.-P., Fang, L.-Y., Yin, D.-L., et al. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i4.872 · Cited by 18
Berberine attenuates 5-fluorouracil-induced intestinal mucosal injury by modulating the gut microbiota without compromising its anti-tumor efficacy
Wu, C., Yang, J., Ye, C., Wu, H., Shu, W., Li, R., Wang, S., Lü, Y., Chen, H., Zhang, Z., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34528 · Cited by 18
Molecular pathways in reproductive cancers: a focus on prostate and ovarian cancer
Ajayi, A. F., Oyovwi, M. O., Akano, O. P., Akanbi, G. B., & Adisa, F. B. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03658-5 · Cited by 18
Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasms
Pandey, R., & Kapur, R. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0388-z · Cited by 18
Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma
Cornelius, A. S., Foley, J. M., Bond, J. P., Nagulapally, A. B., Steinbrecher, J., Hendricks, W. P. D., Rich, M. E., Yendrembam, S., Bergendahl, G., Trent, J. M., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00652 · Cited by 18

Authors: Polivka, J., & Janku, F.
Venue: Pharmacology & Therapeutics
Publisher: Elsevier BV
Published: 2014-05
Volume: 142
Issue: 2
Pages: 164-175
ISSN: 0163-7258 (ISSN-L)
DOI: 10.1016/j.pharmthera.2013.12.004
OpenAlex: W2132052921
Cited by: 765
References: 131
Citations by year: 2026: 20 · 2025: 31 · 2024: 41 · 2023: 71 · 2022: 56 · 2021: 90 · 2020: 80 · 2019: 103 · 2018: 63 · 2017: 71 · 2016: 51 · 2015: 59 · 2014: 28
FWCI: 4.39
Type: journal article
Language: en
Open access: closed
Locations: Pharmacology & Therapeutics (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Oncology › Advanced Breast Cancer Therapies
Keywords: PI3K/AKT/mTOR pathway, targeted cancer therapy, molecular targets, PI3K inhibitors, mTOR inhibitors, everolimus, temsirolimus, MAPK signaling, oncogenic mutations, tumor suppressor, prognostic factors, predictive biomarkers, precision oncology, carcinogenesis
MeSH terms: Phosphoinositide-3 Kinase Inhibitors, Animals, Antineoplastic Agents, Humans, Neoplasms, Drug Design, Signal Transduction, Protein Kinase Inhibitors, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinase, TOR Serine-Threonine Kinases, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks